Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT00425178
PHASE1
FGF-1 for Topical Administration for the Treatment of Diabetic or Venous Stasis Ulcers
Sponsor: Venturis Therapeutics, Inc.
View on ClinicalTrials.gov
Summary
FGF-1 is being used for the treatment of patients with diabetic or venous stasis ulcers. Procedure includes topical administration of FGF-1 or placebo and evaluation of safety, pharmacokinetics, and wound improvement.
Official title: A Phase 1, Open Label, Single Dose, Dose Response, Pilot Study to Evaluate the Safety and Tolerability of Human Fibroblast Growth Factor-1 (FGF-1) in Patients With Diabetic or Venous Stasis Ulcers
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
8
Start Date
2005-09-02
Completion Date
2006-12-01
Last Updated
2026-08-19
Healthy Volunteers
No
Interventions
DRUG
FGF-1
Locations (1)
Warren General Hospital
Warren, Pennsylvania, United States